NO159932C - Fremgangsmaate for fremstilling av substituerte imidazolyl-tiazol-derivater. - Google Patents

Fremgangsmaate for fremstilling av substituerte imidazolyl-tiazol-derivater.

Info

Publication number
NO159932C
NO159932C NO831632A NO831632A NO159932C NO 159932 C NO159932 C NO 159932C NO 831632 A NO831632 A NO 831632A NO 831632 A NO831632 A NO 831632A NO 159932 C NO159932 C NO 159932C
Authority
NO
Norway
Prior art keywords
procedure
substituted imidazolyl
preparing substituted
tiazol
derivatives
Prior art date
Application number
NO831632A
Other languages
English (en)
Other versions
NO159932B (no
NO831632L (no
Inventor
John Lawrence Lamattina
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO831632L publication Critical patent/NO831632L/no
Publication of NO159932B publication Critical patent/NO159932B/no
Publication of NO159932C publication Critical patent/NO159932C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
NO831632A 1982-05-10 1983-05-09 Fremgangsmaate for fremstilling av substituerte imidazolyl-tiazol-derivater. NO159932C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/376,486 US4435396A (en) 1982-05-10 1982-05-10 Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor

Publications (3)

Publication Number Publication Date
NO831632L NO831632L (no) 1983-11-11
NO159932B NO159932B (no) 1988-11-14
NO159932C true NO159932C (no) 1989-02-22

Family

ID=23485203

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831632A NO159932C (no) 1982-05-10 1983-05-09 Fremgangsmaate for fremstilling av substituerte imidazolyl-tiazol-derivater.

Country Status (26)

Country Link
US (1) US4435396A (no)
EP (1) EP0094191B1 (no)
JP (1) JPS58206588A (no)
KR (1) KR860000931B1 (no)
AT (1) ATE33649T1 (no)
AU (2) AU539244B2 (no)
CA (1) CA1201120A (no)
CS (1) CS252461B2 (no)
DD (1) DD209828A5 (no)
DE (1) DE3376322D1 (no)
DK (1) DK163829B (no)
EG (1) EG17029A (no)
ES (1) ES8407045A1 (no)
FI (1) FI78481C (no)
GR (1) GR79279B (no)
GT (1) GT198302123A (no)
HU (2) HU196377B (no)
IE (1) IE55229B1 (no)
IL (1) IL68630A (no)
NO (1) NO159932C (no)
NZ (1) NZ204158A (no)
PL (1) PL141199B1 (no)
PT (1) PT76662B (no)
SU (1) SU1195907A3 (no)
YU (1) YU42857B (no)
ZA (1) ZA833286B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
EP0259085B1 (en) * 1986-08-29 1991-08-21 Pfizer Inc. 2-guanidino-4-arylthiazoles for treatment of peptic ulcers
EP0269239B1 (en) * 1986-10-29 1994-06-08 Pfizer Inc. Processes for 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole and the crystalline dihydrochloride trihydrate thereof
CA2165344A1 (en) * 1993-06-15 1994-12-22 Peter C. Canning Immune stimulants in bacterial infections
PE20110843A1 (es) 2008-09-22 2011-12-08 Cayman Chem Co Derivados de 5-(1h-imidazol-5-il)-2-fenilpirimidina, como inhibidores de prostaglandina d sintasa hematopoyetica
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519637A (en) 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
DE2142585A1 (de) * 1971-08-20 1973-02-22 Schering Ag 2-(5-nitro-2-thiazolyl)-benzimidazole
FR2284601A1 (fr) * 1974-09-10 1976-04-09 Inst Francais Du Petrole Composes guanidino-heterocycliques alkyles, leur preparation et leur utilisation comme additifs pour carburants et lubrifiants
US4220654A (en) 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4374843A (en) * 1980-10-14 1983-02-22 Pfizer Inc. 2-Guanidino-4-heteroarylthiazoles

Also Published As

Publication number Publication date
PT76662B (en) 1986-04-16
EP0094191B1 (en) 1988-04-20
IL68630A0 (en) 1983-09-30
NO159932B (no) 1988-11-14
FI78481B (fi) 1989-04-28
DD209828A5 (de) 1984-05-23
DK163829B (da) 1992-04-06
SU1195907A3 (ru) 1985-11-30
EG17029A (en) 1992-06-30
GR79279B (no) 1984-10-22
IL68630A (en) 1987-03-31
PL141199B1 (en) 1987-07-31
FI78481C (fi) 1989-08-10
NZ204158A (en) 1986-05-09
ES522223A0 (es) 1984-08-16
ATE33649T1 (de) 1988-05-15
PT76662A (en) 1983-06-01
DE3376322D1 (en) 1988-05-26
HU196377B (en) 1988-11-28
HU190899B (en) 1986-12-28
KR860000931B1 (ko) 1986-07-19
FI831595A0 (fi) 1983-05-09
PL241840A1 (en) 1985-01-16
YU99683A (en) 1986-02-28
AU3081584A (en) 1984-11-08
GT198302123A (es) 1984-10-27
CS318483A2 (en) 1987-02-12
DK205883A (da) 1983-11-11
ES8407045A1 (es) 1984-08-16
FI831595L (fi) 1983-11-11
ZA833286B (en) 1984-12-24
AU539244B2 (en) 1984-09-20
CA1201120A (en) 1986-02-25
DK205883D0 (da) 1983-05-09
IE831061L (en) 1983-11-10
NO831632L (no) 1983-11-11
EP0094191A1 (en) 1983-11-16
JPS58206588A (ja) 1983-12-01
US4435396A (en) 1984-03-06
IE55229B1 (en) 1990-07-04
AU566755B2 (en) 1987-10-29
KR840004745A (ko) 1984-10-24
AU1436383A (en) 1983-11-17
YU42857B (en) 1988-12-31
CS252461B2 (en) 1987-09-17

Similar Documents

Publication Publication Date Title
PT73259A (en) Process for preparing novel substituted pyrazinyl-1,2,4-oxadiazole-5-ones
RO86425A (ro) Procedeu pentru prepararea unor derivati ai n-fosfonometilglicinei
RO86824A (ro) Procedeu pentru prepararea unor cefalosporine
NO159932C (no) Fremgangsmaate for fremstilling av substituerte imidazolyl-tiazol-derivater.
RO86319A (ro) Procedeu pentru prepararea unor compusi de benzimidazol
BG42004A3 (en) Method for preparing pyridyl compounds
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
IS2902A7 (is) Aðferð til framleiðslu á 1,8-dihydroxy-10-acyl-9-anthrones, sérstaklega til meðferðar á psoriasis
RO81927A (ro) Procedeu pentru prepararea unor 5-dihidro0ifenoxi-tetrazolil
SE7704110L (sv) Forfarande for framstellning och rening av sekretin
OA06939A (fr) Procédé de préparation de (trialcoxybenzyl)-1 pipérazines.
SE8305386D0 (sv) 15-cycloaliphatic derivatives of 13,14-didehydro-carboprostacyclins and process for their preparation
RO85559A (ro) Procedeu pentru prepararea unor cloracetanilide substituite
FR2507601B1 (fr) Procede de preparation de la 3-methyl-3-(o-methoxyphenoxy)- benzo-2, 4-dioxacyclohaxanone
FI880080A (fi) Foerfarande foer framstaellning av 1,2,3,4-tetrahydro-5h-(1)bensopyrano-(3,4-c)pyridin-5-on.
YU35263B (en) Process for obtaining 6-(aminopheny)-2,3,5,6,-tetrahydroimidazo(2,1-b)thiazole
RO81940A (ro) PROCEDEU PENTRU PREPARAREA UNOR DERIVATI DE 6-HALO-OXO-7-(1-PIPEљAZINIL)-1,8-NAFTIRIDINA
RO89679A2 (ro) Procedeu pentru prepararea unor derivati ai 1-fenil-3-alchilsuccinimido-anilino-5-pirazolonei